Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients

Summary

Patients who have undergone the Fontan procedure (a congenital heart surgery) may develop complications many years after their operation. Studies have shown that some of these patients develop an ongoing inflammatory state, which may be the cause of these late complications. Aspirin is a common over the counter anti-inflammatory medication used for many other chronic diseases. This study may help determine if aspirin therapy can limit the inflammation seen in Fontan patients and prevent these late complications.

Timeline

Start

2016-04

Primary completion

2017-05-25

Completion

2017-05-25

Outcome

Outcome not reported

Stopped (Enrollment): “This study was terminated due to inability to recruit sufficient patients.”

Drugs

Indications

No indication recorded.